Human Molecular Genetics Advance Access published online on August 27, 2003
Human Molecular Genetics, doi:10.1093/hmg/ddg294
© 2003 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Preventive Medicine, Keck School of Medicine, University of Southern California, USC/Norris Comprehensive Cancer Center, 1441 Eastlake Ave., Rm. 4441, Los Angeles, California 90089-9175, USA
* To whom correspondence should be addressed. E-mail: haiman{at}usc.edu.
The CYP19 gene encodes for aromatase (P450arom), a key steroidogenic enzyme that catalyzes the final step of estrogen biosynthesis. Apart from rare mutations in CYP19 which result in severe phenotypes associated with estrogen insufficiency, little is known about whether common variation in CYP19 is associated with risk of hormone-related diseases. In this study, we employed a haplotype-based approach to search for common disease-associated variants in this candidate breast cancer susceptibility gene among African-American, Hawaiian, Japanese, Latina and White women in the Multiethnic Cohort Study (MEC). We utilized 74 densely spaced SNPs (1 every
Article
A Comprehensive Haplotype Analysis of CYP19 and Breast Cancer Risk: The Multiethnic Cohort
2 Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90089
3 Cancer Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813
4 Whitehead/MIT Center for Genome Research, Cambridge, Massachusetts 02139
5 Whitehead/MIT Center for Genome Research, Cambridge, Massachusetts 02139; Department of Genetics and Medicine, Harvard Medical School, Boston, Massachusetts 02115, Department of Molecular Biology and Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts 02114
6 Whitehead/MIT Center for Genome Research, Cambridge, Massachusetts 02139; Division of Endocrinology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115
![]()
Abstract
2.6 kb) spanning 189.4 kb of the CYP19 locus to characterize linkage disequilibrium (LD) and haplotype patterns among 69-70 individuals from each ethnic population. We detected four regions of strong LD (blocks 1-4) that were quite closely conserved across populations. Within each block there was a limited diversity of common haplotypes (5-10 with a frequency
5%) and most haplotypes were observed to be shared across populations. Twenty-five haplotype-tagging SNPs (htSNPs) were selected to predict the common haplotypes with high probability (average Rh2 = 0.92) and genotyped in a breast cancer case-control study in the MEC (cases, n = 1,355; controls, n = 2,580). We first performed global tests for differences in risk according to the common haplotypes and observed significant haplotype-effects in block 2 (P = 0.01; haplotypes 2b (OR = 1.23; 95% CI, 1.07-1.40), 2d (OR = 1.28; 95% CI, 1.01-1.62)). We also found a common long-range haplotype comprised of block-specific haplotypes 2b and 3c to be associated with increased risk of breast cancer (haplotype 2b-3c: OR = 1.31; 95% CI, 1.11-1.54)). Our findings suggest the hypothesis that women with the long-range CYP19 haplotype 2b-3c may be carriers of a predisposing breast cancer susceptibility allele.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K.-D. Yu, G.-H. Di, W.-T. Yuan, L. Fan, J. Wu, Z. Hu, Z.-Z. Shen, Y. Zheng, W. Huang, and Z.-M. Shao Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53 Hum. Mol. Genet., July 1, 2009; 18(13): 2502 - 2517. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cheng, D. O. Stram, N. P. Burtt, L. Gianniny, R. R. Garcia, L. Pooler, B. E. Henderson, L. Le Marchand, and C. A. Haiman IGF2R Missense Single-Nucleotide Polymorphisms and Breast Cancer Risk: The Multiethnic Cohort Study Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1922 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Raskin, F. Lejbkowicz, O. Barnett-Griness, S. Dishon, R. Almog, and G. Rennert BRCA1 Breast Cancer Risk Is Modified by CYP19 Polymorphisms in Ashkenazi Jews Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1617 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Setiawan, J. A. Doherty, X.-o. Shu, M. R. Akbari, C. Chen, I. De Vivo, A. DeMichele, M. Garcia-Closas, M. T. Goodman, C. A. Haiman, et al. Two Estrogen-Related Variants in CYP19A1 and Endometrial Cancer Risk: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 242 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, L. C. Sakoda, J. A. Doherty, M. M. Loomis, S. Fish, R. M. Ray, M. G. Lin, W. Fan, L. P. Zhao, D. L. Gao, et al. Genetic Variation in CYP19A1 and Risk of Breast Cancer and Fibrocystic Breast Conditions among Women in Shanghai, China Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3457 - 3466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T Goodman, G. Lurie, P. J Thompson, K. E McDuffie, and M. E Carney Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk Endocr. Relat. Cancer, December 1, 2008; 15(4): 1055 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Conti, W. Lee, D. Li, J. Liu, D. Van Den Berg, P. D. Thomas, A. W. Bergen, G. E. Swan, R. F. Tyndale, N. L. Benowitz, et al. Nicotinic acetylcholine receptor {beta}2 subunit gene implicated in a systems-based candidate gene study of smoking cessation Hum. Mol. Genet., September 15, 2008; 17(18): 2834 - 2848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Huang, S.-H. Kuo, H.-C. Lien, S.-Y. Yang, S.-L. You, C.-Y. Shen, C.-H. Lin, Y.-S. Lu, and K.-J. Chang The CYP19 TTTA Repeat Polymorphism Is Related to the Prognosis of Premenopausal Stage I-II and Operable Stage III Breast Cancers Oncologist, July 1, 2008; 13(7): 751 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Saltzman, J. F. Yamamoto, R. Decker, L. Yokochi, A. G. Theriault, T. M. Vogt, and L. Le Marchand Association of Genetic Variation in the Transforming Growth Factor {beta}-1 Gene with Serum Levels and Risk of Colorectal Neoplasia Cancer Res., February 15, 2008; 68(4): 1236 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Colomer, M. Monzo, I. Tusquets, J. Rifa, J. M. Baena, A. Barnadas, L. Calvo, F. Carabantes, C. Crespo, M. Munoz, et al. A Single-Nucleotide Polymorphism in the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor Letrozole in Advanced Breast Carcinoma Clin. Cancer Res., February 1, 2008; 14(3): 811 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cai, N. Kataoka, C. Li, W. Wen, J. R. Smith, Y.-T. Gao, X. O. Shu, and W. Zheng Haplotype Analyses of CYP19A1 Gene Variants and Breast Cancer Risk: Results from the Shanghai Breast Cancer Study Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 27 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Setiawan, G. Ursin, P. L. Horn-Ross, D. Van Den Berg, L. Le Marchand, B. E. Henderson, L. Bernstein, and C. A. Haiman Germ Line Variation at 8q24 and Endometrial Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2166 - 2168. [Full Text] [PDF] |
||||
![]() |
S. Rohrmann, W. G. Nelson, N. Rifai, T. R. Brown, A. Dobs, N. Kanarek, J. D. Yager, and E. A. Platz Serum Estrogen, But Not Testosterone, Levels Differ between Black and White Men in a Nationally Representative Sample of Americans J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2519 - 2525. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Tao, Q. Cai, Z.-F. Zhang, W.-H. Xu, N. Kataoka, W. Wen, Y.-B. Xiang, W. Zheng, and X. O. Shu Polymorphisms in the CYP19A1 (Aromatase) Gene and Endometrial Cancer Risk in Chinese Women Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 943 - 949. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Haiman, V. W. Setiawan, L. Y. Xia, L. Le Marchand, S. A. Ingles, G. Ursin, M. F. Press, L. Bernstein, E. M. John, and B. E. Henderson A Variant in the Cytochrome P450 Oxidoreductase Gene Is Associated with Breast Cancer Risk in African Americans Cancer Res., April 15, 2007; 67(8): 3565 - 3568. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Slattery, K. Curtin, R. Baumgartner, C. Sweeney, T. Byers, A. R. Giuliano, K. B. Baumgartner, and R. R. Wolff IL6, Aspirin, Nonsteroidal Anti-inflammatory Drugs, and Breast Cancer Risk in Women Living in the Southwestern United States Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 747 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Haiman, L. Dossus, V. W. Setiawan, D. O. Stram, A. M. Dunning, G. Thomas, M. J. Thun, D. Albanes, D. Altshuler, E. Ardanaz, et al. Genetic Variation at the CYP19A1 Locus Predicts Circulating Estrogen Levels but not Breast Cancer Risk in Postmenopausal Women Cancer Res., March 1, 2007; 67(5): 1893 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Olson, E. V. Bandera, and I. Orlow Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE Review Am. J. Epidemiol., February 1, 2007; 165(3): 235 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. McKay, R. Kaaks, M. Johansson, C. Biessy, F. Wiklund, K. Balter, H.-O. Adami, C. Boillot, L. Gioia-Patricola, F. Canzian, et al. Haplotype-Based Analysis of Common Variation in the Growth Hormone Receptor Gene and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 169 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Setiawan, I. Cheng, D. O. Stram, E. Giorgi, M. C. Pike, D. Van Den Berg, L. Pooler, N. P. Burtt, L. Le Marchand, D. Altshuler, et al. A Systematic Assessment of Common Genetic Variation in CYP11A and Risk of Breast Cancer Cancer Res., December 15, 2006; 66(24): 12019 - 12025. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sun, Y. Gao, W. Tan, S. Ma, X. Zhang, Y. Wang, Q. Zhang, Y. Guo, D. Zhao, C. Zeng, et al. Haplotypes in Matrix Metalloproteinase Gene Cluster on Chromosome 11q22 Contribute to the Risk of Lung Cancer Development and Progression Clin. Cancer Res., December 1, 2006; 12(23): 7009 - 7017. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-R. Long, N. Kataoka, X.-O. Shu, W. Wen, Y.-T. Gao, Q. Cai, and W. Zheng Genetic Polymorphisms of the CYP19A1 Gene and Breast Cancer Survival. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2115 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lu, Q. Wei, M. L. Bondy, D. Li, A. Brewster, S. Shete, T.-K. Yu, A. Sahin, F. Meric-Bernstam, K. K. Hunt, et al. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <=55 years Carcinogenesis, November 1, 2006; 27(11): 2209 - 2216. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Setiawan, C. A. Haiman, F. Z. Stanczyk, L. Le Marchand, and B. E. Henderson Racial/Ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1849 - 1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cheng, K. L. Penney, D. O. Stram, L. Le Marchand, E. Giorgi, C. A. Haiman, L. N. Kolonel, M. Pike, J. Hirschhorn, B. E. Henderson, et al. Haplotype-Based Association Studies of IGFBP1 and IGFBP3 with Prostate and Breast Cancer Risk: The Multiethnic Cohort. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1993 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, D.-H. Xiong, T.-L. Yang, Y.-F. Guo, R. R. Recker, and H.-W. Deng Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females Hum. Mol. Genet., August 15, 2006; 15(16): 2401 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Prentice and L. QI Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation Biostat., July 1, 2006; 7(3): 339 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sweeney, K. Curtin, M. A. Murtaugh, B. J. Caan, J. D. Potter, and M. L. Slattery Haplotype analysis of common vitamin d receptor variants and colon and rectal cancers. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 744 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cheng, D. O. Stram, K. L. Penney, M. Pike, L. Le Marchand, L. N. Kolonel, J. Hirschhorn, D. Altshuler, B. E. Henderson, and M. L. Freedman Common Genetic Variation in IGF1 and Prostate Cancer Risk in the Multiethnic Cohort J Natl Cancer Inst, January 18, 2006; 98(2): 123 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Setiawan, I. Cheng, D. O. Stram, K. L. Penney, L. Le Marchand, D. Altshuler, L. N. Kolonel, J. Hirschhorn, B. E. Henderson, and M. L. Freedman IGF-I Genetic Variation and Breast Cancer: the Multiethnic Cohort Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 172 - 174. [Full Text] [PDF] |
||||
![]() |
C. J. Petry, K. K. Ong, K. F. Michelmore, S. Artigas, D. L. Wingate, A. H. Balen, F. de Zegher, L. Ibanez, and D. B. Dunger Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women Hum. Reprod., July 1, 2005; 20(7): 1837 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Han, D. Kang, J. E. Lee, I. A. Park, J.-Y. Choi, K.-M. Lee, J. Y. Bae, S. Kim, E.-S. Shin, J. E. Lee, et al. A Haplotype Analysis of HER-2 Gene Polymorphisms: Association with Breast Cancer Risk, HER-2 Protein Expression in the Tumor, and Disease Recurrence in Korea Clin. Cancer Res., July 1, 2005; 11(13): 4775 - 4778. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Dunning, M. Dowsett, C. S. Healey, R. N. Luben, E. Folkerd, P. D. P. Pharoah, D. F. Easton, N. E. D. Bruce, and A. J. Ponder RESPONSE: Re: Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women J Natl Cancer Inst, January 19, 2005; 97(2): 153 - 154. [Full Text] [PDF] |
||||
![]() |
C. L. Pearce, J. N. Hirschhorn, A. H. Wu, N. P. Burtt, D. O. Stram, S. Young, L. N. Kolonel, B. E. Henderson, D. Altshuler, and M. C. Pike Clarifying the PROGINS Allele Association in Ovarian and Breast Cancer Risk: A Haplotype-Based Analysis J Natl Cancer Inst, January 5, 2005; 97(1): 51 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Helisalmi, M Hiltunen, S Vepsalainen, S Iivonen, A Mannermaa, M Lehtovirta, A M Koivisto, I Alafuzoff, and H Soininen Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1746 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Freedman, K. L. Penney, D. O. Stram, L. Le Marchand, J. N. Hirschhorn, L. N. Kolonel, D. Altshuler, B. E. Henderson, and C. A. Haiman Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort Hum. Mol. Genet., October 1, 2004; 13(20): 2431 - 2441. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Dunning, M. Dowsett, C. S. Healey, L. Tee, R. N. Luben, E. Folkerd, K. L. Novik, L. Kelemen, S. Ogata, P. D. P. Pharoah, et al. Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women J Natl Cancer Inst, June 16, 2004; 96(12): 936 - 945. [Abstract] [Full Text] [PDF] |
||||












